[Treatment and surveillance of severe chronic respiratory insufficiency].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001945:Breathing Exercises; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D002908:Chronic Disease; D005100:Expectorants / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007738:Kyphosis / Q000150:complications; D008173:Lung Diseases, Obstructive / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D011009:Pneumoconiosis / Q000150:complications; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy*; D012600:Scoliosis / Q000150:complications; D013806:Theophylline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D005938:Glucocorticoids; D002110:Caffeine; D013806:Theophylline
Traitement et surveillance des grandes insuffisances respiratoires chroniques.